ATC Group: A04AA05 Palonosetron

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A04AA05 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A04 Antiemetics and antinauseants
3 A04A Antiemetics and antinauseants
4 A04AA Serotonin (5HT3) antagonists
5 A04AA05 Palonosetron

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.5 mg
PAREN - Parenteral 0.25 mg

Active ingredients in A04AA05

Active Ingredient Description
Palonosetron

Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor.

Related product monographs

Title Information Source Document Type  
ALOXI Soft capsule European Medicines Agency (EU) MPI, EU: SmPC
ALOXI Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
ONICIT Solution for injection Health Products Regulatory Authority (ZA) MPI, Generic

Medicines in this ATC group

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.